JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2002; 40:703-709
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akinboboye, O. O.
Right arrow Articles by Bergmann, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akinboboye, O. O.
Right arrow Articles by Bergmann, S. R.

Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists

A comparison of lisinopril and losartan

Olakunle O. Akinboboye, MD, MPH, FACC*,*, R. u-Ling Chou, PhD{dagger} and Steven R. Bergmann, MD, PhD, FACC{dagger}

* Saint Francis Hospital, Roslyn, State University of New York at StonyBrook, Roslyn, New York, USA
{dagger} Division of Cardiology, Columbia University, New York, New York, USA.



View larger version (26K):

[in a new window]
  		Figure 1 (a) Pre- and post-treatment resting flow values in patients treated with angiotensin-converting enzyme inhibitors (ACEIs). (b) Pre- and post-treatment maximal flow values in patients treated with ACEIs. (c) Pre- and post-treatment myocardial perfusion reserve in patients treated with ACEIs.

 


View larger version (28K):

[in a new window]
  		Figure 2 (a) Pre- and post-treatment resting flow values in patients treated with angiotensin-receptor blockers (ARBs). (b) Pre- and post-treatment maximal flow values in patients treated with ARBs. (c) Pre- and post-treatment myocardial perfusion reserve in patients treated with ARBs.

 


View larger version (32K):

[in a new window]
  		Figure 3 Pre- and post treatment hyperemic flow values in patients treated with angiotensin-receptor blockers (ARBs) (left two bars) and in those treated with angiotensin-converting enzyme (ACE) inhibitors (right two bars) compared with controls (middle).

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.